Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography.
Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders.
CD14 is a key organizer of microglial responses to CNS infection and injury.
Cerebrospinal fluid aquaporin-4 antibody levels in neuromyelitis optica attacks.
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy.
Modulation of B Cell Regulatory Molecules CD22 and CD72 in Myasthenia Gravis and Multiple Sclerosis.
Multiple sclerosis: T-cell resistance to regulation in RRMS linked to IL-6 pathway.
Teriflunomide for oral therapy in multiple sclerosis.
Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis.
Dibutyryl Cyclic AMP Inhibits the Progression of Experimental Autoimmune Encephalomyelitis and Potentiates Recruitment of Endogenous Neural Stem Cells.
Co-Delivery of Autoantigen and B7 Pathway Modulators Suppresses Experimental Autoimmune Encephalomyelitis.
[New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimode].
Avidity of anti-neurocytoskeletal antibodies in cerebrospinal fluid and serum.
Beneficial effects of UV radiation other than via vitamin D production.
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
A Friend in Need May Not be a Friend Indeed: Role of Microglia in Neurodegenerative Diseases.
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis.
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population.
AAV1.NT-3 gene therapy for Charcot-Marie-Tooth neuropathy.
Clinical trials to clinical use: using vision as a model for multiple sclerosis and beyond.
Optical Coherence Tomography versus Visual Evoked Potentials in detecting subclinical visual impairment in multiple sclerosis.
Microglia: The constant gardeners.
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
Latitude, sun exposure and vitamin D supplementation: associations with quality of life and disease outcomes in a large international cohort of people with multiple sclerosis.
Pages
« first
‹ previous
…
252
253
254
255
256
257
258
259
260
…
next ›
last »